![Randal A. Hassler](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Randal A. Hassler
Geen lopende functies
Loopbaan van Randal A. Hassler
Eerdere bekende functies van Randal A. Hassler
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Seattle Biomedical Research Institute
![]() Seattle Biomedical Research Institute Miscellaneous Commercial ServicesCommercial Services Seattle Biomedical Research Institute operates as a non-profit organization that researches and discovers infectious diseases. It provides research for new drugs, vaccines, and diagnostics. The company was founded by Kenneth D. Stuart and Ruth W. Shearer in 1976 and is headquartered in Seattle, WA. | Operationeel Directeur | 01-01-2008 | 01-01-2014 |
Financieel Directeur/CFO | 22-11-2010 | 01-01-2014 | |
AMGEN INC. | Corporate Officer/Principal | 01-01-1995 | 01-01-2007 |
ALDER BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-08-2014 | - |
Opleiding van Randal A. Hassler
Indiana University | Undergraduate Degree |
Colorado State University | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 6 |
Operationeel
Corporate Officer/Principal | 2 |
Chief Operating Officer | 1 |
Director of Finance/CFO | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
AMGEN INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Seattle Biomedical Research Institute
![]() Seattle Biomedical Research Institute Miscellaneous Commercial ServicesCommercial Services Seattle Biomedical Research Institute operates as a non-profit organization that researches and discovers infectious diseases. It provides research for new drugs, vaccines, and diagnostics. The company was founded by Kenneth D. Stuart and Ruth W. Shearer in 1976 and is headquartered in Seattle, WA. | Commercial Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
![]() Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
- Beurs
- Insiders
- Randal A. Hassler
- Ervaring